HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

How academic labs can approach the drug discovery process as a way to synergize with big pharma.

Abstract
While the pharmaceutical industry is facing highly challenging times, the academic drug discovery sector has the potential to contribute meaningfully to the discovery of novel drug targets and to the development of new mode-of-action therapeutics against a range of diseases, including rare and neglected diseases.
AuthorsArianna Loregian, Giorgio Palù
JournalTrends in microbiology (Trends Microbiol) Vol. 21 Issue 6 Pg. 261-4 (Jun 2013) ISSN: 1878-4380 [Electronic] England
PMID23731493 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Ltd. All rights reserved.
Topics
  • Academic Medical Centers (organization & administration)
  • Biomedical Research
  • Drug Discovery
  • Drug Industry (organization & administration)
  • Humans
  • Public-Private Sector Partnerships
  • Universities (organization & administration)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: